Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2024 10:00 ET | Source: Derm-Biome Pharmaceuticals, Inc

Derm-Biome Pharmaceuticals prepares to begin IND-enabling studies for DB-007-4, a potential best-in-class treatment for inflammatory skin diseases

VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company developing novel topical therapies for inflammatory skin...
January 31, 2024 10:47 ET | Source: Research and Markets

Global Crow's Feet Market Analysis Uncovers Growth Trends and Predictions Through 2031

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Crows Feet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user,...
January 24, 2024 05:05 ET | Source: Belle.ai

Fighting leprosy with artificial intelligence: DAHW and Belle.ai join forces with Senegal’s Ministry of Health and Social Action to detect and combat neglected diseases

DAHW, Belle.ai and Senegal's Ministry of Health will deploy Belle.ai’s smartphone-based skin AI software to help Senegal eliminate leprosy by 2030.
November 16, 2023 10:53 ET | Source: Research and Markets

Global Dermatology Devices Market Analysis & Forecast to 2023-2033: Increasing Product Approvals by U.S. FDA is Forecast to Boost Market Growth

Dublin, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The "Global Dermatology Devices Market Analysis & Forecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering.The global...
November 16, 2023 07:45 ET | Source: Palvella Therapeutics

Palvella Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations

QTORIN™ rapamycin has potential to be first approved therapy and standard of care in the U.S. for Microcystic Lymphatic Malformations Microcystic Lymphatic Malformations is a chronically...
October 24, 2023 10:03 ET | Source: Research and Markets

Global Phototherapy Equipment Market Trends Analysis Report 2023-2030: LED-Based Phototherapy Devices Gain Traction, Propelling Market Growth in Skin Disease Treatment

Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Phototherapy Equipment Market Size, Share & Trends Analysis Report By Product (Conventional Phototherapy Equipment), By Application (Skin Diseases...
October 11, 2023 06:12 ET | Source: Belle.ai

ARPA-H Awards $3.5 Million Contract to BelleTorus Corp. (Belle.ai) to Expand Pediatric Healthcare Access Using Artificial Intelligence

ARPA-H awards $3.5 million contract to Belle.ai and UHP to develop an AI-driven pediatric telehealth solution for skin, ear, and throat conditions.
October 02, 2023 06:23 ET | Source: Research and Markets

Dermatology Lasers Market Thrives on Rising Incidences of Skin Cancer and Aesthetic Treatments

Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Dermatology Lasers Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global dermatology lasers market is on...
September 22, 2023 06:58 ET | Source: Research and Markets

Global Dermatology CRO Market 2023-2030: Intellectual Property Challenges Pose Hurdles to Dermatology CRO Industry Growth

Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical...
March 31, 2023 09:38 ET | Source: Research and Markets

Phototherapy Equipment Global Market to Reach $473.5 Billion by 2030: Increasing Number of Preterm Births to Drive the Adoption of Phototherapy Equipment

Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "Phototherapy Equipment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...